Home|Journals|Articles by Year|Audio Abstracts
 

-

IJPRT. 2011; 1(1): 17-20


Formulation and Evaluation of Nanoparticles containing Losartan Potassium

Amar Singh*, Amar Deep.




Abstract

Losartan potassium is an antihypertensive agent used in the treatment of hypertension which has low peak plasma concentration and half-life. It has been selected as candidate for the formulation of sustained release dosage forms. In the present work losartan potassium loaded chitosan nanoparticles were prepared by ionic gelation of chitosan with tripolyphosphate anions. Nanoparticles of different core: coat ratio were formulated and evaluated for drug content, loading efficiency, particles size, zeta potential, In vitro drug release and stability studies. Scanning Electron Microscopy indicated that the nanoparticles were found to be in nanometer range and showed ideal surface morphology. Differ ential scanning calorimetry analysis indicated that there were no chemical interactions between drug and polymer and stability of drug. In vitro release behavior from all the drug loaded batches were found to follow zero order and provided sustained release over a period of 24 hours. No appreciable difference was observed in the extent of degradation of product during 60 days in which nanoparticles were stored at various temperatures. The developed formulation overcomes and could possibility be advantageous in terms of sustained release dosage forms of losartan potassium.

Key words: Nanoparticles, Chitosan, Losartan potassium, Ionic gelation technique.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.